Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database.

The Sentinel Distributed Database (SDD) is a database of patient administrative healthcare records, derived from insurance claims and electronic health records, sponsored by the US Food and Drug Administration for evaluation of medical product outcomes. There is limited information on the validity o...

Descripción completa

Detalles Bibliográficos
Publicado en:Medicine Vol. 97; no. 8; pp. 1 - 8
Autores principales: Ammann, Eric M., Cuker, Adam, Carnahan, Ryan M., Perepu, Usha S., Winiecki, Scott K., Schweizer, Marin L., Leonard, Charles E., Fuller, Candace C., Garcia, Crystal, Haskins, Cole, Chrischilles, Elizabeth A.
Formato: research Journal Article
Publicado: Lippincott Williams & Wilkins Mar2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128175621&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 128175621
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00257974
        2S6
      jtl: Medicine
      issn: 00257974
      maglogo: N
    pubinfo:
      dt: Mar2018
      vid: 97
      iid: 8
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        128175621
        128175621
        NLM29465588
        128175621
        10.1097/MD.0000000000009960
        NLM29465588
        128175621
      ppf: 1
      ppct: 7
      formats:
      tig:
        atl: Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database.
      aug:
        au:
          Ammann, Eric M.
          Cuker, Adam
          Carnahan, Ryan M.
          Perepu, Usha S.
          Winiecki, Scott K.
          Schweizer, Marin L.
          Leonard, Charles E.
          Fuller, Candace C.
          Garcia, Crystal
          Haskins, Cole
          Chrischilles, Elizabeth A.
        affil: College of Public Health, University of Iowa, Iowa City, Iowa.
      sug:
        subj:
          Venous Thromboembolism Diagnosis
          Immunoglobulins, Intravenous Adverse Effects
          Resource Databases Standards
          International Classification of Diseases Standards
          Medical Records Standards
          Pulmonary Embolism Diagnosis
          Reproducibility of Results
          Risk Assessment Statistics and Numerical Data
          Predictive Value of Tests
          Female
          Venous Thromboembolism Chemically Induced
          United States
          Pulmonary Embolism Chemically Induced
          Risk Assessment Standards
          Human
          Hospitalization Statistics and Numerical Data
          Middle Age
          Male
          Venous Thrombosis Chemically Induced
          Venous Thrombosis Diagnosis
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Scales
          Middle Aged: 45-64 years
          Female
          Male
      ab: The Sentinel Distributed Database (SDD) is a database of patient administrative healthcare records, derived from insurance claims and electronic health records, sponsored by the US Food and Drug Administration for evaluation of medical product outcomes. There is limited information on the validity of diagnosis codes for acute venous thromboembolism (VTE) in the SDD and administrative healthcare data more generally.In this chart validation study, we report on the positive predictive value (PPV) of inpatient administrative diagnosis codes for acute VTE-pulmonary embolism (PE) or lower-extremity or site-unspecified deep vein thrombosis (DVT)-within the SDD. As part of an assessment of thromboembolic adverse event risk following treatment with intravenous immune globulin (IGIV), charts were obtained for 75 potential VTE cases, abstracted, and physician-adjudicated.VTE status was determined for 62 potential cases. PPVs for lower-extremity DVT and/or PE were 90% (95% CI: 73-98%) for principal-position diagnoses, 80% (95% CI: 28-99%) for secondary diagnoses, and 26% (95% CI: 11-46%) for position-unspecified diagnoses (originating from physician claims associated with an inpatient stay). Average symptom onset was 1.5 days prior to hospital admission (range: 19 days prior to 4 days after admission).PPVs for principal and secondary VTE discharge diagnoses were similar to prior study estimates. Position-unspecified diagnoses were less likely to represent true acute VTE cases.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N